256 related articles for article (PubMed ID: 31888937)
1. Cost-effectiveness analysis of a physician deployment program to improve access to healthcare in rural and underserved areas in the Philippines.
Avanceña ALV; Tejano KPS; Hutton DW
BMJ Open; 2019 Dec; 9(12):e033455. PubMed ID: 31888937
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas.
Wang H; Kenkel D; Graham ML; Paul LC; Folta SC; Nelson ME; Strogatz D; Seguin RA
BMC Health Serv Res; 2019 May; 19(1):315. PubMed ID: 31096977
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Rural Incentive Packages for Graduating Medical Students in Lao PDR.
Keuffell E; Jaskiewicz W; Theppanya K; Tulenko K
Int J Health Policy Manag; 2017 Jul; 6(7):383-394. PubMed ID: 28812834
[TBL] [Abstract][Full Text] [Related]
4. Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines.
Genuino AJ; Chaikledkaew U; Guerrero AM; Reungwetwattana T; Thakkinstian A
BMC Health Serv Res; 2019 Nov; 19(1):874. PubMed ID: 31752849
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
Ito K; Leslie WD
Osteoporos Int; 2015 Aug; 26(8):2111-9. PubMed ID: 25807913
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting retention in the Philippine National Rural Physician Deployment Program from 2012 to 2019: a mixed methods study.
Flores ELL; Manahan EMR; Lacanilao MPB; Ladaw IMBT; Mallillin MMB; Mappatao NTQ; Leonardia JA; Pepito VCF
BMC Health Serv Res; 2021 Nov; 21(1):1201. PubMed ID: 34740342
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Pediatric Cochlear Implantation in Rural China.
Qiu J; Yu C; Ariyaratne TV; Foteff C; Ke Z; Sun Y; Zhang L; Qin F; Sanderson G
Otol Neurotol; 2017 Jul; 38(6):e75-e84. PubMed ID: 28379918
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
9. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
10. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
11. Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.
Gomez GB; Foster N; Brals D; Nelissen HE; Bolarinwa OA; Hendriks ME; Boers AC; van Eck D; Rosendaal N; Adenusi P; Agbede K; Akande TM; Boele van Hensbroek M; Wit FW; Hankins CA; Schultsz C
PLoS One; 2015; 10(9):e0139048. PubMed ID: 26413788
[TBL] [Abstract][Full Text] [Related]
12. Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines.
Haasis MA; Ceria JA; Kulpeng W; Teerawattananon Y; Alejandria M
PLoS One; 2015; 10(7):e0131156. PubMed ID: 26131961
[TBL] [Abstract][Full Text] [Related]
13. A Cost-Effectiveness Analysis of a Pediatric Operating Room in Uganda.
Yap A; Muzira A; Cheung M; Healy J; Kakembo N; Kisa P; Cunningham D; Youngson G; Sekabira J; Yaesoubi R; Ozgediz D
Surgery; 2018 Nov; 164(5):953-959. PubMed ID: 29801729
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
15. Five-year cost-effectiveness analysis of the European Fans in Training (EuroFIT) physical activity intervention for men versus no intervention.
Kolovos S; Finch AP; van der Ploeg HP; van Nassau F; Broulikova HM; Baka A; Treweek S; Gray CM; Jelsma JGM; Bunn C; Roberts GC; Silva MN; Gill JMR; Røynesdal Ø; van Mechelen W; Andersen E; Hunt K; Wyke S; Bosmans JE
Int J Behav Nutr Phys Act; 2020 Mar; 17(1):30. PubMed ID: 32131849
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of integrated community case management delivery models utilizing drug sellers and community health workers for treatment of under-five febrile cases of malaria, pneumonia, diarrhoea in rural Uganda.
Lubogo P; Lukyamuzi JE; Kyambadde D; Komakech AA; Kitutu FE; Mulogo EM
Malar J; 2021 Oct; 20(1):407. PubMed ID: 34663345
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers.
Rattay T; Dumont IP; Heinzow HS; Hutton DW
Gastroenterology; 2017 Dec; 153(6):1531-1543.e2. PubMed ID: 29074450
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of primarily surgical versus primarily conservative treatment of acute and subacute radiculopathies due to intervertebral disc herniation from the Swiss perspective.
Ademi Z; Gloy V; Glinz D; Raatz H; Van Stiphout J; Bucher HC; Schwenkglenks M
Swiss Med Wkly; 2016; 146():w14382. PubMed ID: 27922167
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B
Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
